|1||Active, not recruiting||
Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast Cancer
Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients
† Study has passed its completion date and status has not been verified in more than two years.